These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30539871)

  • 1. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
    Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1201-S1208. PubMed ID: 30539871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
    Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
    J Cancer Res Ther; 2020; 16(4):737-744. PubMed ID: 32930112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations.
    Park JY; Jang SH; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Seo J; Lee CY; Ko Y; Park YB
    BMC Cancer; 2019 Jun; 19(1):574. PubMed ID: 31196060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
    Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD
    Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
    Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
    Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis.
    Frost N; Zhamurashvili T; von Laffert M; Klauschen F; Ruwwe-Glösenkamp C; Raspe M; Brunn M; Ochsenreither S; Temmesfeld-Wollbrück B; Suttorp N; Grohé C; Witzenrath M
    Clin Lung Cancer; 2020 Nov; 21(6):e607-e621. PubMed ID: 32620471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.
    Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z
    Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of lymph node micrometastasis at the pN₀ stage of lung adenocarcinoma using a combination of markers.
    Liu H; Ye YK; Li GM; Zhou Y; Han KB; Xu G; Wang D
    Genet Mol Res; 2014 Jul; 13(3):5594-600. PubMed ID: 25117316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
    Piljić Burazer M; Mladinov S; Ćapkun V; Kuret S; Glavina Durdov M
    Med Sci Monit; 2017 Jan; 23():489-497. PubMed ID: 28128193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy.
    Doherty MK; O'Connor E; Hannon D; O'Reilly A; Yen D; Redmond M; Grogan LM; Hennessy BT; Breathnach OS; Morris PG
    Ir J Med Sci; 2019 Feb; 188(1):69-74. PubMed ID: 29948461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
    Xu Y; Zheng M; Wang N; Wang R
    Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Thyroid Transcription Factor-1 and Tumor differentiation in Resected Lung Adenocarcinoma.
    Huang TW; Lin KF; Lee CH; Chang H; Lee SC; Shieh YS
    Sci Rep; 2017 Oct; 7(1):14222. PubMed ID: 29079814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 7 and thyroid transcription factor - 1 levels in patients with lung cancer complicated with superior vena cava syndrome and their correlation with clinicopathological characteristics.
    Tong L; Xu H
    J BUON; 2019; 24(6):2294-2302. PubMed ID: 31983097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.
    Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB
    Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
    La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
    Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
    Wang Y; Wu Y; Li J; Li J; Che G
    Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
    Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K
    Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma].
    Zu Y; Wang X; Liu X; Chen Y; Li C; Shang X; Xie Y; Zhao H; Wang J
    Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):131-7. PubMed ID: 23514941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual surrogate markers for rapid prediction of epidermal growth factor receptor mutation status in advanced adenocarcinoma of the lung: A novel approach in resource-limited setting.
    Udupa KS; Rajendranath R; Sagar TG; Sundersingh S; Joseph T
    Indian J Cancer; 2015; 52(3):266-8. PubMed ID: 26905105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.